Powerful antipsychotic medicines are being used far too cavalierly in children, and federal drug regulators must do more to warn doctors of their substantial risks, a panel of federal drug experts said Tuesday.

http://www.nytimes.com/2008/11/19/health/policy/19fda.html

This entry was posted on Sunday, November 30th, 2008 at 6:27 pm and is filed under Academic. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.